Anke Sparmann

2.4k total citations · 2 hit papers
10 papers, 1.9k citations indexed

About

Anke Sparmann is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Anke Sparmann has authored 10 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 2 papers in Oncology and 2 papers in Genetics. Recurrent topics in Anke Sparmann's work include RNA modifications and cancer (2 papers), CRISPR and Genetic Engineering (2 papers) and RNA regulation and disease (2 papers). Anke Sparmann is often cited by papers focused on RNA modifications and cancer (2 papers), CRISPR and Genetic Engineering (2 papers) and RNA regulation and disease (2 papers). Anke Sparmann collaborates with scholars based in Germany, Netherlands and United States. Anke Sparmann's co-authors include Maarten van Lohuizen, Dafna Bar‐Sagi, Jörg Vogel, Gaetano Gargiulo, Michiel Vermeulen, Els Verhoeven, Juergen A. Knoblich, Matthias Mann, Yunli Xie and Cesare Lancini and has published in prestigious journals such as Nature reviews. Cancer, The EMBO Journal and Cancer Cell.

In The Last Decade

Anke Sparmann

9 papers receiving 1.8k citations

Hit Papers

Polycomb silencers control cell fate, development and cancer 2004 2026 2011 2018 2006 2004 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anke Sparmann Germany 5 1.3k 544 427 366 145 10 1.9k
Kevin Roarty United States 18 1.0k 0.8× 662 1.2× 249 0.6× 283 0.8× 169 1.2× 22 1.6k
Mario Di Matteo Belgium 15 803 0.6× 481 0.9× 335 0.8× 745 2.0× 160 1.1× 20 1.6k
Alessandra Rustighi Italy 26 1.6k 1.2× 575 1.1× 439 1.0× 314 0.9× 113 0.8× 38 2.0k
Verónica Rodilla Spain 12 951 0.7× 557 1.0× 270 0.6× 155 0.4× 200 1.4× 14 1.4k
Jan van Riggelen United States 17 1.3k 1.0× 483 0.9× 333 0.8× 201 0.5× 95 0.7× 20 1.7k
Liqin Zhu United States 14 920 0.7× 846 1.6× 282 0.7× 277 0.8× 171 1.2× 29 1.6k
Lauren D. Wood United States 16 1.2k 0.9× 580 1.1× 335 0.8× 196 0.5× 87 0.6× 20 1.7k
Chang‐Il Hwang United States 19 936 0.7× 559 1.0× 589 1.4× 202 0.6× 102 0.7× 34 1.6k
Jane B. Clarke United States 17 1.0k 0.8× 608 1.1× 509 1.2× 707 1.9× 154 1.1× 24 2.0k
Roderik M. Kortlever United States 13 1.0k 0.8× 614 1.1× 388 0.9× 334 0.9× 72 0.5× 15 1.6k

Countries citing papers authored by Anke Sparmann

Since Specialization
Citations

This map shows the geographic impact of Anke Sparmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anke Sparmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anke Sparmann more than expected).

Fields of papers citing papers by Anke Sparmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anke Sparmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anke Sparmann. The network helps show where Anke Sparmann may publish in the future.

Co-authorship network of co-authors of Anke Sparmann

This figure shows the co-authorship network connecting the top 25 collaborators of Anke Sparmann. A scholar is included among the top collaborators of Anke Sparmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anke Sparmann. Anke Sparmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Vogel, Jörg, et al.. (2025). ASOBIOTICS 2024: an interdisciplinary symposium on antisense-based programmable RNA antibiotics. RNA. 31(4). 465–474. 3 indexed citations
2.
Sparmann, Anke & Jörg Vogel. (2023). RNA ‐based medicine: from molecular mechanisms to therapy. The EMBO Journal. 42(21). e114760–e114760. 66 indexed citations
3.
Sparmann, Anke. (2021). HP1 shapes embryonic genome architecture. Nature Structural & Molecular Biology. 28(5). 412–412. 2 indexed citations
4.
Sparmann, Anke. (2019). piRNAs — guardians of the germline. 1 indexed citations
5.
Sparmann, Anke. (2017). RNA base-pairing drives phase transitions. Nature Structural & Molecular Biology. 24(6). 502–502. 1 indexed citations
6.
Sparmann, Anke. (2015). m6A drives structural changes in RNA. Nature Structural & Molecular Biology. 22(3). 184–184.
7.
Sparmann, Anke, Yunli Xie, Els Verhoeven, et al.. (2013). The chromodomain helicase Chd4 is required for Polycomb‐mediated inhibition of astroglial differentiation. The EMBO Journal. 32(11). 1598–1612. 69 indexed citations
8.
Sparmann, Anke & Maarten van Lohuizen. (2006). Polycomb silencers control cell fate, development and cancer. Nature reviews. Cancer. 6(11). 846–856. 1029 indexed citations breakdown →
9.
Sparmann, Anke & Dafna Bar‐Sagi. (2005). Ras Oncogene and Inflammation: Partners in Crime. Cell Cycle. 4(6). 735–736. 18 indexed citations
10.
Sparmann, Anke & Dafna Bar‐Sagi. (2004). Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis. Cancer Cell. 6(5). 447–458. 666 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026